In addition, CD44 expression was positively associated with MMP-2 and MMP-9 in the ccRCC group, and correlated with nuclear grade, thus suggesting the contribution of these molecular markers to aggressiveness in ccRCC [142,143]. This evidence concerns the gene MMP2 and nonpapillary renal cell carcinoma.